Nadia Bianco
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients.
Journal: JAMA network open
Published: May 04, 2026
Breast surgery and systemic treatment continuation for patients with de novo metastatic breast cancer and locoregional oligoprogression: a cohort study.
Journal: ESMO open
Published: September 17, 2025
Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study.
Journal: Breast (Edinburgh, Scotland)
Published: September 14, 2025
Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.
Journal: The oncologist
Published: June 16, 2025
Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.
Journal: The oncologist
Published: June 16, 2025
Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 11, 2024
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: January 15, 2024
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland.
Journal: Journal of cancer survivorship : research and practice
Published: February 16, 2022
Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial.
Journal: Current oncology (Toronto, Ont.)
Published: October 17, 2021
Last Updated: 09/26/2026